Trails Edge Capital Partners, LP 13F Holdings · Q2 2026
Trails Edge Capital Partners, LP reported 35 securities worth $629.91M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: LBRX (7.85%), NRIX (6.06%), IMCR (5.36%). Among its top 25 positions this quarter: 8 new, 10 added, 6 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LBRX | LB PHARMACEUTICALS INC | $49.4M | 7.85% | 1.5M | Added |
| 2 | NRIX | NURIX THERAPEUTICS INC | $38.2M | 6.06% | 1.6M | Trimmed |
| 3 | IMCR | IMMUNOCORE HLDGS PLC | $33.8M | 5.36% | 1.1M | Added |
| 4 | TRAX | FIRST TRACKS BIOTHERAPEUTICS | $30.5M | 4.84% | 1.5M | New |
| 5 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $29.6M | 4.70% | 2.2M | Added |
| 6 | BMRN | BIOMARIN PHARMACEUTICAL INC | $29.3M | 4.65% | 512,000 | New |
| 7 | DSGN | DESIGN THERAPEUTICS INC | $29.0M | 4.60% | 2.0M | Added |
| 8 | XENE | XENON PHARMACEUTICALS INC | $26.6M | 4.22% | 440,000 | Trimmed |
| 9 | MIRM | MIRUM PHARMACEUTICALS INC | $26.1M | 4.15% | 223,312 | Trimmed |
| 10 | CYTK | CYTOKINETICS INC | $24.5M | 3.90% | 288,089 | Trimmed |
| 11 | INSM | INSMED INC | $24.6M | 3.90% | 230,331 | New |
| 12 | SNDX | SYNDAX PHARMACEUTICALS INC | $24.3M | 3.85% | 1.1M | Added |
| 13 | NGNE | NEUROGENE INC | $22.5M | 3.57% | 714,885 | Trimmed |
| 14 | KLRA | KAILERA THERAPEUTICS INC | $21.7M | 3.44% | 984,786 | New |
| 15 | RVMD | REVOLUTION MEDICINES INC | $21.7M | 3.44% | 115,750 | Trimmed |
| 16 | IKT | INHIBIKASE THERAPEUTICS INC | $18.4M | 2.92% | 9.1M | Added |
| 17 | INCY | INCYTE CORP | $17.6M | 2.79% | 155,000 | New |
| 18 | AVTX | AVALO THERAPEUTICS INC | $16.5M | 2.62% | 891,881 | New |
| 19 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $14.6M | 2.32% | 750,000 | New |
| 20 | FTH | FAETH THERAPEUTICS INC | $12.9M | 2.05% | 515,335 | Added |
| 21 | XFOR | X4 PHARMACEUTICALS INC | $12.0M | 1.91% | 2.6M | Hold |
| 22 | IRD | OPUS GENETICS INC | $11.3M | 1.79% | 2.7M | Added |
| 23 | SLGL | SOL-GEL TECHNOLOGIES LTD | $10.3M | 1.64% | 139,445 | Added |
| 24 | AURA | AURA BIOSCIENCES INC | $10.2M | 1.63% | 1.4M | New |
| 25 | IPSC | CENTURY THERAPEUTICS INC | $10.1M | 1.61% | 4.1M | Added |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR